Sage Journals: Discover world-class research

Free access

Research article

First published 2006-6

Downregulation of PIK3CB by siRNA Suppresses Malignant Glioma Cell Growth In Vitro and In Vivo

Peiyu Pu, Chunsheng Kang, Zhiyong Zhang [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2022-11

PIK3CA Mutational Analysis in Patients With Macrodactyly

Jakob Becker, Ulrike Camenisch Gross, Daniel M Weber [...]

Pediatric and Developmental Pathology

Retricted access

Research article

First published 2023-4

BYL719 (alpelisib) for the treatment of PIK3CA-mutated,recurrent/advanced cervical cancer

Giorgio Bogani, Valentina Chiappa, Marta Bini [...]

Tumori Journal

Free access

Research article

First published 2022-04-11

In vitro effect of PIK3CA/mTOR inhibition in triple-negative breast cancer subtype cell lines

Sandeep Kumar, Shalmoli Bhattacharyya, Ashim Das [...]

Breast Disease

Open access

Research article

First published 2020

Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women

Jing Lian, En-Wei Xu, Yan-Feng Xi [...]

Technology in Cancer Research & Treatment

Free access

Research article

First published 2016-8

Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma

Ali M. Al-Amri, Chittibabu Vatte, Cyril Cyrus [...]

Cancer Biomarkers

Retricted access

Case report

First published 2017-2

Prenatal Detection of PIK3CA-related Overgrowth Spectrum in Cultured Amniocytes Using Long-range PCR and Next-generation Sequencing

Elizabeth Quinlan-Jones, Denise Williams, Charlotte Bell [...]

Pediatric and Developmental Pathology

Open access

Research article

First published 2026

Economic Evaluation of Inavolisib Combined With Palbociclib–Fulvestrant for PIK3CA-Mutated,HR+/HER2− Advanced Breast Cancer in USA

Hanqing Zeng, Li-Ying Song, Ren Guo [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2025

Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated,HR-positive,HER2-negative invasive breast cancer: A systematic review

Chris Larck, Joseph B Elmes, R. Wesley Haynes [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2018-5

ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study

Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki [...]

Cancer Biomarkers

Search results